Evidence map›Paper›PMID 30029497›Full record

ArticleGenes2018

Application of Whole Exome and Targeted Panel Sequencing in the Clinical Molecular Diagnosis of 319 Chinese Families with Inherited Retinal Dystrophy and Comparison Study.

Likun Wang, Jinlu Zhang, Ningning Chen, Lei Wang, Fengsheng Zhang, Zhizhong Ma, Genlin Li, Liping Yang

Open access · goldAbstract read
In one paragraph

Article in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 83 citations in OpenAlex.

  1. Trial
  2. Genetic characterization of inherited retinal dystrophy in a Northwestern Chinese cohort: A single-center study over a 5-year period in Shaanxi, China.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  3. Restoring Sight: The Journey of AIPL1 from Discovery to Therapy.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Likun WangInstitute of Systems Biomedicine & Department of Ophthalmology, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing 100191, China. wanglk@bjmu.edu.cn.ORCID 0000-0002-0933-2808
Jinlu ZhangInstitute of Systems Biomedicine & Department of Ophthalmology, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing 100191, China. zhangjinlu@bjmu.edu.cn.
Ningning ChenInstitute of Systems Biomedicine & Department of Ophthalmology, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing 100191, China. ningningchen12@163.com.
Lei WangBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing 100730, China. wl998295@163.com.
Fengsheng ZhangHuhehaote Chaoju Eye Hospital, No. 40, W. Railway Station Road New City District, Huhehaote 010050, China. zhangfengsheng@chaojueye.cn.
Zhizhong MaInstitute of Systems Biomedicine & Department of Ophthalmology, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing 100191, China. puh3_yk@bjmu.edu.cn.
Genlin LiBeijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Lab, Beijing 100730, China. ligenglin@263.net.
Liping YangInstitute of Systems Biomedicine & Department of Ophthalmology, School of Basic Medical Sciences, Third Hospital, Peking University, Beijing 100191, China. alexlipingyang@bjmu.edu.cn.
Peking University · CNBeijing Tongren Hospital · CNAnyang Eye Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inherited retinal dystrophies (IRDs) are a group of clinically and genetically heterogeneous diseases involving more than 280 genes and no less than 20 different clinical phenotypes. In this study, our aims were to identify the disease-causing gene variants of 319 Chinese patients with IRD, and compare the pros and cons of targeted panel sequencing and whole exome sequencing (WES). Patients were assigned for analysis with a hereditary eye disease enrichment panel (HEDEP) or WES examination based on time of recruitment. This HEDEP was able to capture 441 hereditary eye disease genes, which included 291 genes related to IRD. As

Indexed as

inherited retinal dystrophymolecular diagnosistargeted panel sequencingwhole exome sequencing

Identifiers

PMID30029497
PMCPMC6071067
OpenAlexW2883352634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.